Paloma Partners Management CO Gilead Sciences, Inc. Transaction History

Paloma Partners Management CO

$3.28 Billion
Q2 2024

A detailed history of Paloma Partners Management CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Paloma Partners Management CO holds 11,400 shares of GILD stock, worth $953,154. This represents 0.02% of its overall portfolio holdings.

Number of Shares

11,400

Previous 28,092 59.42%

Holding current value

$953,154

Previous $2.06 Million 61.98%

% of portfolio

0.02%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $1.35 Million - $1.56 Million	-21,392 Reduced 76.15%	6,700 $459,000
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $1.61 Million - $1.97 Million	22,523 Added 404.44%	28,092 $2.06 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $408,040 - $462,728	5,569 New	5,569 $451,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $185,575 - $232,546	3,204 Added 106.8%	6,204 $369,000
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $194,640 - $220,920	3,000 New	3,000 $218,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.19 Million - $1.3 Million	-18,719 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $538,740 - $614,702	-8,979 Reduced 32.42%	18,719 $1.21 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.57 Million - $1.79 Million	27,698 New	27,698 $1.61 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $10.7 Million - $13.5 Million	-173,081 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $9.27 Million - $10.8 Million	128,137 Added 285.1%	173,081 $13.3 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.95 Million - $2.5 Million	-31,206 Reduced 40.98%	44,944 $3.36 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $297,994 - $327,784	-4,836 Reduced 5.97%	76,150 $4.95 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $301,923 - $333,270	-4,830 Reduced 5.63%	80,986 $5.13 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $2.64 Million - $2.96 Million	42,620 Added 98.67%	85,816 $5.8 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.24 Million - $1.39 Million	19,773 Added 84.42%	43,196 $2.81 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $1.21 Million - $1.57 Million	19,905 Added 565.8%	23,423 $1.47 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $199,800 - $243,578	-2,743 Reduced 43.81%	3,518 $266,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $1.54 Million - $1.81 Million	-21,634 Reduced 77.56%	6,261 $449,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $2.01 Million - $2.38 Million	27,895	27,895 $2.26 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account

Paloma Partners Management CO Gilead Sciences, Inc. Transaction History